Advertisement

Brain Tumor Pathology

, 26:69 | Cite as

Recurrence and regrowth of benign meningiomas

  • Satoshi NakasuEmail author
  • Tadateru Fukami
  • Jyunya Jito
  • Kazuhiko Nozaki
Original Article

Abstract

The World Health Organization (WHO) grading system for meningioma is helpful for predicting aggressive subtypes. However, even benign meningiomas sometimes show relatively rapid growth and may recur after total removal. We attempted to find histopathological features that would be valuable for predicting recurrence or regrowth of WHO grade I meningiomas. We investigated 135 benign meningiomas, of which 120 were totally removed (Simpson’s grade I–III). The median follow-up period was 9.7 years (1–21 years). The recurrence rate in the patients with total removal was 7.5% at 10 years and 9.3% at 20 years. The univariate analysis revealed that MIB-1 index (≥2%), existence of mitosis, absence of calcification, and paucity of fibrosis significantly correlated with recurrence. On the other hand, the histological features of sheet-like growth, prominent nucleoli, and necrosis did not correlate with recurrence, because they were relatively rare in grade I tumors. Multivariate analysis revealed that high MIB-1 index and absence of calcification significantly correlated with recurrence. The patients with recurrent or residual tumors did not always receive adjuvant treatment. Including subtotally treated tumors, the retreatment rate was 9.8% at 10 years and 25.6% at 20 years. MIB-1 index and Simpson’s grade significantly correlated with retreatment in both univariate and multivariate analyses.

Key words

Calcification Fibrosis Meningioma MIB-1 Recurrence 

References

  1. 1.
    Ho DM, Hsu CY, Ting LT, et al (2002) Histopathology and MIB-1 labeling index predicted recurrence of meningiomas: a proposal of diagnostic criteria for patients with atypical meningioma. Cancer (Phila) 94:1538–1547CrossRefGoogle Scholar
  2. 2.
    Jääskeläinen J, Haltia M, Servo A (1986) Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome. Surg Neurol 25:233–242.CrossRefPubMedGoogle Scholar
  3. 3.
    Perry A, Salford SI, Sceithauer BW, et al (1997) Meningioma grading. An analysis of histologic parameters. Am J Surg Pathol 21:1455–1465CrossRefPubMedGoogle Scholar
  4. 4.
    Louis DN, Scheithauer BW, von Deimling A, et al (2000) Meningiomas. In: Kleiheus P, Cavenee WK (eds) WHO classification of tumours of the central nervous system. IARC, Lyon, pp 176–184Google Scholar
  5. 5.
    Perry A, Louis DN, Scheithauer BW, et al (2007) Meningioma. In: Louis DN, Ohgaki H, Wiestler OD, Caveneee WK (eds) WHO classification of tumours of the central nervous system. IARC, Lyon, pp 163–172Google Scholar
  6. 6.
    Kasuya H, Kubo O, Tanaka M, et al (2006) Clinical and radiological features related to the growth potential of meningioma. Neurosurg Rev 29:293–296CrossRefPubMedGoogle Scholar
  7. 7.
    Nakasu S, Nakajima M, Matsumura K, et al (1995) Meningioma: proliferating potential and clinicoradiological features. Neurosurgery 37:1049–1055CrossRefPubMedGoogle Scholar
  8. 8.
    Maiuri F, Iaconetta G, de Divitiis O, et al (1999) Intracranial meningiomas: correlations between MR imaging and histology. Eur J Radiol 31:69–75CrossRefPubMedGoogle Scholar
  9. 9.
    Soyama N, Kuratsu J, Ushio Y (1995) Correlation between magnetic resonance images and histology in meningiomas: T2-weighted images indicate collagen contents in tissues. Neurol Med Chir 35:438–441CrossRefGoogle Scholar
  10. 10.
    Suzuki Y, Sugimoto T, Shibuya M, et al (1994) Meningiomas: correlation between MRI characteristics and operative finding including consistency. Acta Neurochir 129:39–46CrossRefGoogle Scholar
  11. 11.
    Nakasu S, Li D-H, Okabe H, et al (2001) Significance of MIB-1 staining indices in meningiomas. Comparison of two counting methods. Am J Surg Pathol 25:472–478CrossRefPubMedGoogle Scholar
  12. 12.
    Simpson D (1957) The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20:22–39CrossRefPubMedGoogle Scholar
  13. 13.
    Vankalakuniti M, Vasishta RK, das Rodorta B, et al (2007) MIB-1 immunolabeling: a valuable marker in prediction of benign recurring meningiomas. Neuropathology 27:407–412CrossRefGoogle Scholar
  14. 14.
    Roser F, Samii M, Ostertag H, et al (2004) The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases. Acta Neurochir (Wien) 146:37–44CrossRefGoogle Scholar
  15. 15.
    Takeuchi H, Kubota T, Kabuto M, et al (1997) Prediction of recurrence in histologically benign meningiomas: proliferating cell nuclear antigen and Ki-67 immunohistochemical study. Surg Neurol 48:501–508CrossRefPubMedGoogle Scholar
  16. 16.
    Takahashi JA, Ueba T, Hashimoto N, et al (2004) The combination of mitotic and Ki-67 indices as a useful method for predicting short-term recurrence of meningiomas. Surg Neurol 61:149–155CrossRefPubMedGoogle Scholar
  17. 17.
    Tyagi A, Chakrabarty A, Franks A (2004) MIB1 proliferation index in meningiomas: does it predict recurrence? A clinicopathological study. Br J Neurosurg 18:357–361CrossRefPubMedGoogle Scholar
  18. 18.
    Maiuri F, DeCaro Model B, Esposito F, et al (2007) Recurrences of meningiomas: predictive value of pathological features and hormonal and growth factor. J Neuro-Oncol 82:63–68CrossRefGoogle Scholar
  19. 19.
    Matsuno A, Fujimaki T, Sasaki T, et al (1996) Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomas. Acta Neuropathol (Berl) 91:504–510CrossRefGoogle Scholar
  20. 20.
    Kim YJ, Ketter R, Steudel WI, et al (2007) Prognostic significance of the mitotic index using the mitosis marker anti-phosphohistone H3 in meningiomas. Am J Clin Pathol 128:118–125CrossRefPubMedGoogle Scholar
  21. 21.
    Rezanko T, Akkalp AK, Tunakan M, et al (2008) MIB-1 counting methods in meningiomas and agreement among pathologists. Anal Quant Cytol Histol 30:47–52PubMedGoogle Scholar
  22. 22.
    Kim YJ, Ketter R, Henn W, et al (2006) Histopathologic indicators of recurrence in meningiomas: correlation with clinical and genetic parameters. Virchows Arch 449:529–538CrossRefPubMedGoogle Scholar
  23. 23.
    Pfisterer WK, Coons SW, Aboul-Enein F, et al (2008) Implicating chromosomal aberrations with meningioma growth and recurrence: results from FISH and MIB-1 analysis of grade I and II meningioma tissue. J Neuro-Oncol 87:43–50CrossRefGoogle Scholar
  24. 24.
    Maillo A, Orfao A, Espinosa AB, et al (2007) Early recurrences in histologically benign/grade I meningiomas are associated with large tumors and coexistence of monosomy 14 and del(1p36) in the ancestral tumor cell clone. Neurooncology 9:438–446Google Scholar

Copyright information

© Japan Soceity of BrainTumor Pathology 2009

Authors and Affiliations

  • Satoshi Nakasu
    • 1
    Email author
  • Tadateru Fukami
    • 2
  • Jyunya Jito
    • 2
  • Kazuhiko Nozaki
    • 2
  1. 1.Division of Neurosurgery and NeurooncologyKusatsu General HospitalShigaJapan
  2. 2.Department of NeurosurgeryShiga University of Medical ScienceShigaJapan

Personalised recommendations